Guerbet SA
EPA:GBT.PA
Overview | Financials
Company Name | Guerbet SA |
Symbol | GBT.PA |
Currency | EUR |
Price | 29.85 |
Market Cap | 376,377,993 |
Dividend Yield | 1.35% |
52-week-range | 16.86 - 40.25 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. David Hale |
Website | https://www.guerbet.com |
An error occurred while fetching data.
About Guerbet SA
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD